Studies HIV levels in people on long-term HIV medicines
Checks whether HIV levels stay low in adults taking HIV medicines for a long time.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Analysis of HIV-1 Replication During Antiretroviral Therapy
- Status
- Enrolling by invitation
- People taking part
- 70 people, planned
- Started
- 17 Nov 2008
- Type of study
- Observational
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults living with HIV who have taken antiretroviral therapy for a long time and have very low virus levels in the blood.
- Age
- 18 years and older (up to 99 years)
- Sex
- All sexes can join.
- Disease stage
- HIV infection confirmed by a reactive ELISA and a positive western blot. Virus in the blood is kept below 50 copies/mL on treatment, or went below 50 copies/mL and then came back during treatment.
- Earlier treatment
- Must have taken part in the NIH protocol 00-I-0110 or 97-I-0082, or have been followed long term at NIH where extra samples are useful. Stored samples from before treatment must be available.
- Biomarker or test result
- bDNA virus level below 50 copies/mL, or a rebound of the virus during treatment after it had gone below 50 copies/mL.
Main reasons for not taking part
- Was withdrawn from an earlier study because of not following study procedures
- No private doctor for routine medical care
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age greater than or equal to 18 years
- HIV infection with documented reactive ELISA and positive western blot
- Prior enrollment in 00-I-0110, 97-I-0082 OR patients with long term evaluation at NIH for whom additional sampling will be useful for protocol objectives, including:; Available stored specimens from pretherapy period; Ongoing suppression of viremia with bDNA less than 50 copies/mL, OR; Suppression of viremia to less than 50 copies/mL followed by rebound viremia during therapy
- Patients must have a private physician for routine medical care
Who cannot take part
- Any prospective study subject who has been previously withdrawn from any prior study for inability to comply with study procedures will be considered ineligible for this study
Other criteria
- INCLUSION CRITERIA:
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study will determine if the level of virus in HIV-infected patients taking antiretroviral medications for prolonged periods decreases or persists at a stable level. It will also examine whether new gene changes (mutations) occur during drug suppression.
Read full original descriptionShow less
HIV-infected patients who are 18 years of age or older, have been enrolled in another NIH protocol, have been suppressed on antiretroviral therapy and have very low levels of virus in their blood may be eligible for this 5-year (or more) study.
Participants come to the NIH Clinical Center about every 6 months for a physical examination, routine and research blood tests and leukapheresis to collect white blood cells for T cell analysis. For leukapheresis, blood is collected through a vein much like donating whole blood, but the blood is directed through a machine that separates and extracts the white cells and returns the rest of the blood components to the patient. Patients may also have an optional third clinic visit each year for another blood draw.
The group in the trial
- Patients
HIV-infected patients who are 18 years of age or older, have been enrolled in another NIH protocol.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Analysis of HIV-1 Replication During Antiretroviral Therapy
- Plain-language title
- Studies HIV levels in people on long-term HIV medicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00767312, who can take part
- Record updated
- 29 October 2026